Assets of Pharmaceutical Company

Sale of assets of Neopharma, Inc which includes:

1. The Intangible Rights (as defined in the APA).
2. The Pharmaceutical Products (as defined in the APA) including Neopharma’s drug authorizations and the documents referenced in the regulatory chronology for each NDA, each ANDA and each IND (as defined in the APA).
3. Neopharma’s interest in any confidentiality agreements, non-disclosure agreements, and non-compete agreements relating to the assignment of ideas and inventions to Neopharma by its current or past employees.
4. The name “Neopharma”, “Neopharma Tennessee LLC” and any logos or marks associated therewith.
5. All Governmental Authorizations (as defined in the APA) granted by any Governmental Agency (as defined in the APA) in connection with the operations of the Pharmaceutical Business, the Intangible Rights and the Real Property.
6. The Real Property and the improvements thereon, including fixtures and leasehold improvements.
7. All the fixed and tangible assets owned by the Sellers and used in the Pharmaceutical Business.
8. All inventory located on, warehoused or stored at the Property.
9. Neopharma Tennessee’s rights as tenant under the Facility Lease.
10. All security deposits related to utility or security services.
11. All tangible assets of the Sellers, other than the Excluded Assets (as defined in the APA).